Skip to main content
Erschienen in: Journal of General Internal Medicine 11/2013

01.11.2013 | Original Research

Mammography Use Among Women Ages 40–49 After the 2009 U.S. Preventive Services Task Force Recommendation

verfasst von: Lauren D. Block, MD, MPH, Marian P. Jarlenski, MPH, Albert W. Wu, MD, MPH, Wendy L. Bennett, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

In 2009, the U.S. Preventive Service Task Force changed its recommendation regarding screening mammography in average-risk women aged 40–49 years.

OBJECTIVE

To evaluate the effects of the 2009 recommendation on reported mammogram use in a population-based survey.

DESIGN

Secondary data analysis of data collected in the 2006, 2008, and 2010 Behavioral Risk Factor Surveillance System surveys.

PARTICIPANTS

Women ages 40–74 years in the 50 states and Washington, DC who were not pregnant at time of survey and reported data on mammogram use during the 2006, 2008, or 2010 survey.

MAIN MEASURES

Mammogram use was compared between women ages 40–49 and women ages 50–74 before and after the recommendation. We performed a difference-in-difference estimation adjusted for access to care, education, race, and health status, and stratified analyses by whether women reported having a routine checkup in the prior year.

KEY RESULTS

Reported prevalence of mammogram use in the past year among women ages 40–49 and 50–74 was 53.2 % and 65.2 %, respectively in 2008, and 51.7 % and 62.4 % in 2010. In 2010, mammography use did not significantly decline from 2006–2008 in women ages 40–49 relative to women ages 50–74.

CONCLUSION

There was no reduction in mammography use among younger women in 2010 compared to older women and previous years. Patients and providers may have been hesitant to comply with the 2009 recommendation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat US Preventive Services. Task force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;151:716–726.CrossRef US Preventive Services. Task force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;151:716–726.CrossRef
2.
Zurück zum Zitat Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: Systematic evidence review update for the U.S. Preventive Services Task Force. Evidence review update. Rockville: Agency for Healthcare Research and Quality; 2009. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: Systematic evidence review update for the U.S. Preventive Services Task Force. Evidence review update. Rockville: Agency for Healthcare Research and Quality; 2009.
3.
Zurück zum Zitat Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med. 2009;151:727–37.PubMedCrossRef Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med. 2009;151:727–37.PubMedCrossRef
4.
Zurück zum Zitat Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Int Med. 2012;156(7):491–9.PubMedCrossRef Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Int Med. 2012;156(7):491–9.PubMedCrossRef
5.
Zurück zum Zitat Partridge AH, Winer EP. On mammography—more agreement than disagreement. N Engl J Med. 2009;361:2499–501.PubMedCrossRef Partridge AH, Winer EP. On mammography—more agreement than disagreement. N Engl J Med. 2009;361:2499–501.PubMedCrossRef
6.
Zurück zum Zitat DeAngelis CD, Fontanarosa PB. U.S. preventive services task force and breast cancer screening. JAMA. 2010;303(2):173–4.CrossRef DeAngelis CD, Fontanarosa PB. U.S. preventive services task force and breast cancer screening. JAMA. 2010;303(2):173–4.CrossRef
7.
Zurück zum Zitat Squiers LB, Holden DJ, Dolina SE, et al. The public’s response to the U.S. preventive services task force’s 2009 recommendations on mammography screening. Am J Prev Med. 2010;40(5):497–504.CrossRef Squiers LB, Holden DJ, Dolina SE, et al. The public’s response to the U.S. preventive services task force’s 2009 recommendations on mammography screening. Am J Prev Med. 2010;40(5):497–504.CrossRef
8.
Zurück zum Zitat Davidson AS, Liao X, Magee D. Attitudes of women in their forties toward the 2009 USPSTF mammogram guidelines: a randomized trial on the effects of media exposure. Am J Obstet Gynecol. 2011;205:e1–7.PubMedCrossRef Davidson AS, Liao X, Magee D. Attitudes of women in their forties toward the 2009 USPSTF mammogram guidelines: a randomized trial on the effects of media exposure. Am J Obstet Gynecol. 2011;205:e1–7.PubMedCrossRef
10.
Zurück zum Zitat Hinz EK, Kudesia R, Rolston R, et al. Physician knowledge of and adherence to the revised breast cancer screening guidelines by the U.S. preventive services. Task Force. Am J Obstet Gynecol. 2011;205:201. e1-5.PubMedCrossRef Hinz EK, Kudesia R, Rolston R, et al. Physician knowledge of and adherence to the revised breast cancer screening guidelines by the U.S. preventive services. Task Force. Am J Obstet Gynecol. 2011;205:201. e1-5.PubMedCrossRef
11.
Zurück zum Zitat Miller JW, King JB, Ryerson AB, et al. Mammography use from 2000–6: state-level trends with corresponding breast cancer incidence rates. Am J Roentology. 2009;192:352–60.CrossRef Miller JW, King JB, Ryerson AB, et al. Mammography use from 2000–6: state-level trends with corresponding breast cancer incidence rates. Am J Roentology. 2009;192:352–60.CrossRef
12.
Zurück zum Zitat Ryerson AB, Miller JQ, Eheman CR, et al. Recent trends in U.S. mammography use from 2000–6: a population-based analysis. Prev Med. 2008;47:477–82.PubMedCrossRef Ryerson AB, Miller JQ, Eheman CR, et al. Recent trends in U.S. mammography use from 2000–6: a population-based analysis. Prev Med. 2008;47:477–82.PubMedCrossRef
14.
Zurück zum Zitat Meissner HI, Klabunde CN, Han PK, et al. Breast cancer screening beliefs, recommendations, and practices. Cancer. 2011;117:3101–11.PubMedCrossRef Meissner HI, Klabunde CN, Han PK, et al. Breast cancer screening beliefs, recommendations, and practices. Cancer. 2011;117:3101–11.PubMedCrossRef
15.
Zurück zum Zitat Bellizzi KM, Breslau ES, Burness A, et al. Prevalence of cancer screening in older and racially diverse adults. Arch Intern Med. 2011;171(22):2031–37.PubMedCrossRef Bellizzi KM, Breslau ES, Burness A, et al. Prevalence of cancer screening in older and racially diverse adults. Arch Intern Med. 2011;171(22):2031–37.PubMedCrossRef
16.
Zurück zum Zitat Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer. 2013. doi:10.1002/cncr.28105. Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer. 2013. doi:10.​1002/​cncr.​28105.
17.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2006, 2008, and 2010. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2006, 2008, and 2010.
18.
Zurück zum Zitat Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soc Prev Med. 2001;46:S03–S42.CrossRef Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soc Prev Med. 2001;46:S03–S42.CrossRef
19.
Zurück zum Zitat Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women’s self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomark Prev. 2003;12:1182. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women’s self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomark Prev. 2003;12:1182.
21.
Zurück zum Zitat Lambrew JM, Defriese GH, Carey TS, Ricketts TC, Biddle AK. The effects of having a regular doctor on access to primary care. Med Care. 1996;34(2):138–51.PubMedCrossRef Lambrew JM, Defriese GH, Carey TS, Ricketts TC, Biddle AK. The effects of having a regular doctor on access to primary care. Med Care. 1996;34(2):138–51.PubMedCrossRef
22.
Zurück zum Zitat Shoen C, DesRoches C. Uninsured and unstably insured: the importance of continuous insurance coverage. Health Serv Res. 2000;35(1):187–203. Shoen C, DesRoches C. Uninsured and unstably insured: the importance of continuous insurance coverage. Health Serv Res. 2000;35(1):187–203.
23.
Zurück zum Zitat Bertrand M, Duflo E, Mullainathan S. How much should we trust difference-in-differences estimates? Q J Econ. 2004;119(1):249–75.CrossRef Bertrand M, Duflo E, Mullainathan S. How much should we trust difference-in-differences estimates? Q J Econ. 2004;119(1):249–75.CrossRef
24.
Zurück zum Zitat Norton EC, Wang H, Ai C. Computing interaction effects and standard errors in logit and probit models. Stata J. 2004;4(2):154–67. Norton EC, Wang H, Ai C. Computing interaction effects and standard errors in logit and probit models. Stata J. 2004;4(2):154–67.
25.
Zurück zum Zitat Volpp KG, Rosen AK, Rosenbaum PR, et al. Mortality among medicare beneficiaries in the first two years following ACGME resident duty hour reform. JAMA. 2007;298(9):975–83.PubMedCrossRef Volpp KG, Rosen AK, Rosenbaum PR, et al. Mortality among medicare beneficiaries in the first two years following ACGME resident duty hour reform. JAMA. 2007;298(9):975–83.PubMedCrossRef
26.
Zurück zum Zitat Karaca-Mandic P, Norton EC, Dowd B. Interaction terms in nonlinear models. Health Serv Res. 2012;47(1):255–274.PubMedCrossRef Karaca-Mandic P, Norton EC, Dowd B. Interaction terms in nonlinear models. Health Serv Res. 2012;47(1):255–274.PubMedCrossRef
28.
Zurück zum Zitat Nutting PA, Baier M, Werner JJ, Cutter G, Conry C, Stewart L. Competing demands in the office visit: what influences mammography recommendations. J Am Board Fam Pract. 2001;14:352–61.PubMed Nutting PA, Baier M, Werner JJ, Cutter G, Conry C, Stewart L. Competing demands in the office visit: what influences mammography recommendations. J Am Board Fam Pract. 2001;14:352–61.PubMed
29.
Zurück zum Zitat Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, United States, 1989–2005. Vaccine. 2008;26(14):1786–93.PubMedCrossRef Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, United States, 1989–2005. Vaccine. 2008;26(14):1786–93.PubMedCrossRef
30.
Zurück zum Zitat Smith RA, Cokkinides V, Brookes D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American cancer society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99–119.PubMedCrossRef Smith RA, Cokkinides V, Brookes D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American cancer society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99–119.PubMedCrossRef
31.
Zurück zum Zitat Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomark Prev. 2006;15(2):389–94.CrossRef Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomark Prev. 2006;15(2):389–94.CrossRef
32.
Zurück zum Zitat Zelaidt SB, Hoffman RM, Etzioni R, et al. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst. 2011;103:520–3.CrossRef Zelaidt SB, Hoffman RM, Etzioni R, et al. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst. 2011;103:520–3.CrossRef
33.
Zurück zum Zitat Feldman S. Making sense of the new cervical cancer screening guidelines. N Engl J Med. 2011;365:2145–47.PubMedCrossRef Feldman S. Making sense of the new cervical cancer screening guidelines. N Engl J Med. 2011;365:2145–47.PubMedCrossRef
34.
Zurück zum Zitat Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007;57(2):105–11.PubMedCrossRef Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007;57(2):105–11.PubMedCrossRef
35.
Zurück zum Zitat Rauscher GH, Johnson TP, Cho YI, et al. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17:748–57.CrossRef Rauscher GH, Johnson TP, Cho YI, et al. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17:748–57.CrossRef
36.
Zurück zum Zitat Craig BM, Quinn GP, Vadaparampil ST. Sensitivity of self-report mammography use in older women. Am J Prev Med. 2009;37(5):441–4.PubMedCrossRef Craig BM, Quinn GP, Vadaparampil ST. Sensitivity of self-report mammography use in older women. Am J Prev Med. 2009;37(5):441–4.PubMedCrossRef
37.
Zurück zum Zitat Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089–96.PubMedCrossRef Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089–96.PubMedCrossRef
Metadaten
Titel
Mammography Use Among Women Ages 40–49 After the 2009 U.S. Preventive Services Task Force Recommendation
verfasst von
Lauren D. Block, MD, MPH
Marian P. Jarlenski, MPH
Albert W. Wu, MD, MPH
Wendy L. Bennett, MD, MPH
Publikationsdatum
01.11.2013
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 11/2013
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2482-5

Weitere Artikel der Ausgabe 11/2013

Journal of General Internal Medicine 11/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.